Yanyan Tudor

472 total citations
11 papers, 183 citations indexed

About

Yanyan Tudor is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Yanyan Tudor has authored 11 papers receiving a total of 183 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Genetics. Recurrent topics in Yanyan Tudor's work include Pancreatic and Hepatic Oncology Research (2 papers), Mast cells and histamine (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Yanyan Tudor is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Mast cells and histamine (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Yanyan Tudor collaborates with scholars based in United States. Yanyan Tudor's co-authors include Violeta Yu, Randall W. Hungate, Hongjie Deng, Sunita Badola, Rui Tang, Celia Dominguez, Hedy L. Kindler, Scott D. Patterson, Jennifer Gansert and Nuria Tamayo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Yanyan Tudor

10 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanyan Tudor United States 7 94 67 50 33 26 11 183
Verónica Rodríguez Italy 7 201 2.1× 56 0.8× 37 0.7× 48 1.5× 23 0.9× 10 339
Lara Ward United Kingdom 8 172 1.8× 72 1.1× 37 0.7× 10 0.3× 18 0.7× 14 263
Lynn Wood United Kingdom 9 230 2.4× 63 0.9× 61 1.2× 28 0.8× 46 1.8× 12 350
Yiwen Zhang China 9 102 1.1× 53 0.8× 35 0.7× 28 0.8× 26 1.0× 28 246
Christelle Soudy United Kingdom 6 169 1.8× 38 0.6× 31 0.6× 13 0.4× 17 0.7× 7 257
Howard R. Sauls United States 6 141 1.5× 45 0.7× 71 1.4× 59 1.8× 18 0.7× 7 305
Shevan Silva New Zealand 8 145 1.5× 70 1.0× 137 2.7× 24 0.7× 78 3.0× 18 354
Maysoun Shomali United States 6 105 1.1× 31 0.5× 95 1.9× 47 1.4× 23 0.9× 10 244
Jean Shearin United States 8 132 1.4× 139 2.1× 51 1.0× 29 0.9× 35 1.3× 8 427
A. Jestel Germany 6 213 2.3× 88 1.3× 51 1.0× 22 0.7× 39 1.5× 8 341

Countries citing papers authored by Yanyan Tudor

Since Specialization
Citations

This map shows the geographic impact of Yanyan Tudor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanyan Tudor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanyan Tudor more than expected).

Fields of papers citing papers by Yanyan Tudor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanyan Tudor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanyan Tudor. The network helps show where Yanyan Tudor may publish in the future.

Co-authorship network of co-authors of Yanyan Tudor

This figure shows the co-authorship network connecting the top 25 collaborators of Yanyan Tudor. A scholar is included among the top collaborators of Yanyan Tudor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanyan Tudor. Yanyan Tudor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lanman, Brian A., Ryan P. Wurz, Rati Verma, et al.. (2025). Abstract ND01: AMG 410: An H/NRAS-sparing pan-KRAS inhibitor with dual GTP(on)/GDP(off)-state activity for the treatment of diverse KRAS-mutant tumors. Cancer Research. 85(8_Supplement_2). ND01–ND01.
2.
Jin, Hyun Yong, Yanyan Tudor, Kaylee Choi, et al.. (2019). High-Throughput Implementation of the NanoBRET Target Engagement Intracellular Kinase Assay to Reveal Differential Compound Engagement by SIK2/3 Isoforms. SLAS DISCOVERY. 25(2). 215–222. 11 indexed citations
3.
McCaffery, Ian, Yanyan Tudor, Hongjie Deng, et al.. (2013). Putative Predictive Biomarkers of Survival in Patients with Metastatic Pancreatic Adenocarcinoma Treated with Gemcitabine and Ganitumab, an IGF1R Inhibitor. Clinical Cancer Research. 19(15). 4282–4289. 54 indexed citations
4.
McCaffery, Ian, Yanyan Tudor, Hepu Deng, et al.. (2011). Effect of baseline (BL) biomarkers on overall survival (OS) in metastatic pancreatic cancer (mPC) patients (pts) treated with ganitumab (GAN; AMG 479) or placebo (P) in combination with gemcitabine (G).. Journal of Clinical Oncology. 29(15_suppl). 4041–4041. 6 indexed citations
5.
McCaffery, Ian, et al.. (2009). Analysis of cell surface erythropoietin receptor (EpoR) expression and function in human epithelial tumor tissues. Journal of Clinical Oncology. 27(15_suppl). 11104–11104. 3 indexed citations
6.
Chen, Ning, Roland W. Bürli, Susana Neira, et al.. (2008). Discovery of a potent and selective c-Kit inhibitor for the treatment of inflammatory diseases. Bioorganic & Medicinal Chemistry Letters. 18(14). 4137–4141. 6 indexed citations
7.
Kunz, Roxanne K., Dawei Zhang, Andrew S. Tasker, et al.. (2008). Discovery of amido-benzisoxazoles as potent c-Kit inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5115–5117. 10 indexed citations
8.
Hu, Essa, Andrew S. Tasker, Ryan D. White, et al.. (2008). Discovery of Aryl Aminoquinazoline Pyridones as Potent, Selective, and Orally Efficacious Inhibitors of Receptor Tyrosine Kinase c-Kit. Journal of Medicinal Chemistry. 51(11). 3065–3068. 37 indexed citations
9.
Yu, Violeta, Yanyan Tudor, Clarence Hale, et al.. (2007). High Capacity Homogeneous Non-Radioactive Cortisol Detection Assays for Human 11 β -Hydroxysteroid Dehydrogenase Type 1. Assay and Drug Development Technologies. 5(1). 105–116. 1 indexed citations
10.
Ross, Sandra L., Teresa C. Chen, Violeta Yu, et al.. (2006). High-Content Screening Analysis of the p38 Pathway: Profiling of Structurally Related p38 α Kinase Inhibitors Using Cell-Based Assays. Assay and Drug Development Technologies. 4(4). 397–409. 15 indexed citations
11.
Tamayo, Nuria, David Powers, Yanyan Tudor, et al.. (2005). Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase. Bioorganic & Medicinal Chemistry Letters. 15(9). 2409–2413. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Verónica Rodríguez Breakdown of academic impact, for papers by Lara Ward Breakdown of academic impact, for papers by Lynn Wood Breakdown of academic impact, for papers by Yiwen Zhang Breakdown of academic impact, for papers by Christelle Soudy Breakdown of academic impact, for papers by Howard R. Sauls Breakdown of academic impact, for papers by Shevan Silva Breakdown of academic impact, for papers by Maysoun Shomali Breakdown of academic impact, for papers by Jean Shearin Breakdown of academic impact, for papers by A. Jestel
Rankless by CCL
2026